Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH)—previously known as nonalcoholic ...

Identify the warning signs of hepatitis before they become serious. From subtle fatigue to more obvious symptoms, recognizing liver inflammation early can save.

The liver is essential for digestion, metabolism, detoxification, and fluid regulation. While alcohol abuse is a known cause ...

Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...

One of these is non-alcoholic steatohepatitis, or NASH, the fatty liver disease that affects millions of people and which is poised to be one of pharma’s next big growth areas. Novartis ramped ...

Researchers at Georgetown University have developed a new drug called CTPI-2, which targets a key gene known as Slc25a1. This ...

NASH is a form of non-alcoholic fatty liver disease (NAFLD) that affects millions of people and which, for several years, has been billed as pharma's next big growth area. Although, so far efforts ...

[62] There was impaired Apo B100 formation in subjects with NASH compared with normal controls. It is, however, unclear if this effect was specific for NAFLD or simply a function of liver disease.

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic ...